• LAST PRICE
    38.4350
  • TODAY'S CHANGE (%)
    Trending Down-0.7050 (-1.8012%)
  • Bid / Lots
    38.2900/ 4
  • Ask / Lots
    38.4200/ 5
  • Open / Previous Close
    39.1100 / 39.1400
  • Day Range
    Low 37.3800
    High 39.1100
  • 52 Week Range
    Low 25.5700
    High 75.0167
  • Volume
    395,823
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 39.03
TimeVolumeGPCR
09:32 ET561337.96
09:34 ET345238.165
09:36 ET50037.51
09:38 ET80037.52
09:39 ET130037.72
09:41 ET180437.51
09:43 ET280937.6201
09:45 ET161138.045
09:48 ET577337.55
09:50 ET216737.87
09:52 ET50037.88
09:54 ET433437.775
09:56 ET216738.07
09:57 ET102038.08
09:59 ET316537.96
10:01 ET230038.07
10:03 ET146738.11
10:06 ET320137.84
10:08 ET621837.78
10:10 ET40037.65
10:12 ET195037.39
10:14 ET560137.525
10:15 ET670137.79
10:17 ET103737.7
10:19 ET203037.81
10:21 ET180037.75
10:24 ET370137.72
10:26 ET557437.68
10:28 ET161537.72
10:30 ET155037.55
10:32 ET352237.56
10:33 ET330137.58
10:35 ET80037.6
10:37 ET88537.58
10:39 ET40037.68
10:42 ET260037.71
10:44 ET474037.75
10:46 ET116537.86
10:48 ET65037.89
10:50 ET65037.81
10:51 ET204837.6325
10:53 ET20037.74
10:55 ET83437.66
10:57 ET943337.94
11:00 ET120038.07
11:02 ET235137.91
11:04 ET20037.82
11:06 ET30037.93
11:08 ET290037.91
11:09 ET75637.935
11:11 ET270038
11:13 ET494937.99
11:15 ET109038
11:18 ET265437.855
11:20 ET166337.95
11:22 ET20037.895
11:24 ET131538
11:26 ET90037.935
11:27 ET215938.07
11:29 ET100038.13
11:31 ET70038.06
11:33 ET85037.97
11:36 ET35038.07
11:38 ET120037.995
11:40 ET193137.9625
11:42 ET60038.06
11:44 ET130037.995
11:45 ET10037.95
11:47 ET284237.83
11:49 ET30037.71
11:51 ET20037.745
11:54 ET125737.84
11:56 ET113637.91
11:58 ET60037.97
12:00 ET110037.84
12:02 ET110137.86
12:03 ET103737.88
12:05 ET10037.96
12:07 ET321837.825
12:09 ET56737.81
12:12 ET10037.86
12:14 ET358537.795
12:16 ET35837.795
12:18 ET308437.79
12:20 ET189237.79
12:21 ET139637.76
12:23 ET20037.79
12:25 ET192737.86
12:27 ET80937.88
12:30 ET20037.87
12:32 ET113737.86
12:34 ET141738.01
12:36 ET276437.87
12:38 ET30037.9399
12:39 ET318237.85
12:41 ET134037.765
12:43 ET104137.64
12:45 ET116737.6075
12:48 ET272037.81
12:52 ET20037.77
12:54 ET120037.89
12:56 ET20037.91
12:57 ET136737.78
12:59 ET75237.78
01:01 ET60037.74
01:03 ET66837.73
01:06 ET244537.87
01:08 ET85038.03
01:10 ET99838.03
01:12 ET30037.94
01:14 ET149837.97
01:15 ET167938.1125
01:17 ET31938.12
01:19 ET60038.02
01:21 ET125438.08
01:24 ET166938.16
01:26 ET217638.26
01:28 ET80938.28
01:30 ET10038.22
01:32 ET206338.08
01:33 ET10038.07
01:35 ET137438.1
01:37 ET100438.05
01:39 ET20038.065
01:42 ET109238.18
01:44 ET68038.19
01:46 ET834838.395
01:48 ET10038.35
01:50 ET60038.35
01:51 ET110038.24
01:53 ET74238.25
01:55 ET10138.26
01:57 ET60438.33
02:00 ET90038.3
02:02 ET90038.25
02:04 ET50038.2
02:06 ET50038.08
02:08 ET120038.12
02:09 ET169238.23
02:11 ET78138.3
02:13 ET10038.24
02:15 ET131838.32
02:18 ET30038.46
02:20 ET70038.405
02:22 ET62038.415
02:24 ET182238.3225
02:26 ET701338.57
02:27 ET1292038.72
02:29 ET1061338.587
02:31 ET105038.59
02:33 ET1188538.44
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGPCR
Structure Therapeutics Inc
2.2B
-16.6x
---
United StatesAPGE
Apogee Therapeutics Inc
2.2B
-19.0x
---
United StatesIOVA
Iovance Biotherapeutics Inc
2.3B
-4.3x
---
United StatesCGON
CG Oncology Inc
2.0B
-28.2x
---
United StatesJANX
Janux Therapeutics Inc
2.1B
-33.7x
---
United StatesRCKT
Rocket Pharmaceuticals Inc
1.9B
-7.2x
---
As of 2024-06-28

Company Information

Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.

Contact Information

Headquarters
611 Gateway Blvd Suite 223SOUTH SAN FRANCISCO, CA, United States 94080
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Daniel Welch
Chief Executive Officer, Director
Raymond Stevens
Chief Financial Officer
Jun Yoon
Chief Technology Officer
Yingli Ma
Chief Scientific Officer
Xichen Lin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.2B
Revenue (TTM)
$0.00
Shares Outstanding
57.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.32
Book Value
$9.76
P/E Ratio
-16.6x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.